AI research assistant
Ask the Atlas
Ask a question about gene editing in plain language. The answer is assembled only from this site's own sourced records, and it links back to the pages it used.
Try one of these
What CRISPR treatments are FDA approved?Which companies are developing gene-editing treatments for muscular dystrophy?Explain base editing to a 12-year-old.What is the difference between CRISPR and gene therapy?Which gene-editing trials are in Phase III?Which companies are working on in vivo gene editing?What diseases are being targeted by prime editing?How is Casgevy made?How it works — and its limits
It only reads our database. Your question is matched against Atlas records — technologies, diseases, treatments, trials, companies, scientists, genes and the glossary — and only those records are sent to the language model. It cannot browse the web.
It will say when it does not know. If the Atlas holds nothing relevant, it tells you that instead of guessing.
It can still be wrong. Language models paraphrase, and paraphrase can distort. Follow the links and check the sources on the page before relying on anything.
It is not a doctor. It cannot tell you whether a treatment or trial is right for you or anyone else. It will not try.
Rate limited. A few questions a minute per visitor, to keep it available for everyone.
Or start from a page
Most questions are answered faster by opening the record itself — these are the pages the assistant reaches for most often.
Technology
CRISPR-Cas9
A protein that can be programmed with a short RNA guide to find one specific sequence in a genome…
Treatment
Casgevy (exagamglogene autotemcel)
The first CRISPR-based medicine approved anywhere in the world — a one-time therapy made from a…
Technology
Base Editing
Chemically converts one DNA letter into another at a chosen position, without cutting both strands…
Treatment
Lyfgenia (lovotibeglogene autotemcel)
Approved on the same day as Casgevy for sickle cell disease — but a gene-addition therapy, not gene…
Technology
Prime Editing
Writes a new stretch of DNA sequence directly into a chosen site, using a guide that carries the…
Treatment
Zynteglo (betibeglogene autotemcel)
An approved gene-addition therapy for transfusion-dependent beta thalassemia — the non-editing…
Treatment
Nexiguran ziclumeran (nex-z)
The first CRISPR therapy ever administered into a human bloodstream — a single infusion intended to…
Technology
CRISPR-Cas12
A family of CRISPR nucleases that cut DNA leaving staggered ends, use a different sequence…